The PIERS Experience: Research or Quality Improvement?

Journal of Obstetrics and Gynaecology Canada

Volumn 34, Issue 4, 2012, Pages 379-381

  Firoz, Tabassum ^a   Magee, Laura A ^a,b   Payne, Beth A ^a,b   Menzies, Jennifer M ^a,b   von Dadelszen, Peter ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Consent; Ethics boards; Pregnancy research; Quality improvement

Indexed keywords

COST; HUMAN; INFORMED CONSENT; MEDICAL INFORMATION; MEDICAL LITERATURE; MEDICAL RECORD REVIEW; MEDICAL RESEARCH; NOTE; RESEARCH ETHICS; STANDARDIZATION; TOTAL QUALITY MANAGEMENT; ARTICLE; FEMALE; HEALTH CARE QUALITY; HEALTH PROMOTION; INTERNATIONAL COOPERATION; MATERNAL WELFARE; METHODOLOGY; MULTICENTER STUDY (TOPIC); PATHOPHYSIOLOGY; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDY;

FEMALE; HEALTH PROMOTION; HUMANS; INFORMED CONSENT; INTERNATIONAL COOPERATION; MATERNAL WELFARE; MULTICENTER STUDIES AS TOPIC; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; QUALITY IMPROVEMENT; QUALITY OF HEALTH CARE;

EID: 84864741745     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)35221-5     Document Type: Note

References (14)

1. Linstone H.A., Turoff M. The Delphi Method: techniques and applications. Reading 1975, Adison-Wesley, MA, ISBN 9780201042948. Available at:, Accessed January 11, 2012. http://is.njit.edu/pubs/delphibook.
2. Wells P.S., Ginsberg J.S., Anderson D.R., Kearon C., Gent M., Turpie A.G., et al. Use of a clinical model for safe management of patients with suspected pulmonary embolism. Ann Intern Med 1998, 129:997-1005.
3. von Dadelszen P., Payne B., Li J., Ansermino J.M., Broughton Pipkin F., Douglas M.J., et al. .; for the PIERS Study Group. Prediction of adverse maternal outcomes in pre-eclampsia: development and validation of the fullPIERS model. Lancet 2011, 377(9761):219-227. Comment in Lancet 2011;377(9761):185-6.
4. PIERS Calculator. Available at: Accessed August 23, 2011. http://piers.cfri.ca/PIERSCalculatorH.aspx.
5. Payne B., Magee L.A., Anne-Marie Cote, Hutcheon J.A., Li J.i., Kyle P.M., et al. PIERS proteinuria: relationship with adverse maternal and perinatal outcome. J Obstet Gynaecol Can 2011, 33:588-597.
6. Millman A.L., Payne B., Ziguang Qu, Douglas J., Hutcheon J.A., Lee T., et al. Oxygen saturation as a predictor of adverse maternal outcomes in women with pre-eclampsia. J Obstet Gynaecol Can 2011, 33:705-714.
7. American College of Surgeons. Continuous quality improvement. Available at:Accessed October 17, 2011. http://www.facs.org/cqi/index.html.
8. Bellin E., Dubler N.N. The quality improvement-research divide and the need for external oversight. Am J Public Health 2001, 91:1512-1517.
9. Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada. Tri-Council policy statement: ethical conduct for involving humans 2010, Available at:, Accessed July 28, 2011. http://www.pre.ethics.gc.ca/pdf/eng/tcps2/TCPS_2_FINAL_Web.pdf.
10. Menzies J., Magee L.A., Li J., Macnab Y.C., Yin R., Stuart H., et al. Instituting surveillance guidelines and adverse outcomes in preeclampsia. Obstet Gynecol 2007, 110:121-127.
11. Kho M.E., Duffet M., Willison D.J., Cook D.J., Brouwers M.C. Written informed consent and selection bias in observational studies using medical records: systematic review. BMJ 2009, 338:b866.
12. Tu J.V., Willison D.J., Silver F.L., Fang J., Richards J.A., Laupacis A., et al. Impracticability of informed consent in the Registry of the Canadian Stroke Network. N Engl J Med 2004, 350:1414-1421.
13. Willison D.J., Kapral M.K., Peladeau P., Richards J.A., Fang J., Silver F.L. Variation in recruitment across sites in a consent-based clinical data registry: lessons from the Canadian Stroke Network. BMC Med Ethics 2006, 7:1-8.
14. Hansson M. Do we need a wider view of autonomy in epidemiological research?. BMJ 2010, 340:1172-1174.